Scancell Holdings plc (AIM:SCLP)
London · Delayed Price · Currency is GBP · Price in GBX 15.00
+0.75 (5.26%)
Jul 6, 2026, 4:05 PM GMT
Scancell Holdings Market Cap
Scancell Holdings has a market cap or net worth of 147.88 million as of July 6, 2026. Its market cap has increased by 51.54% in one year.
Market Cap
147.88M
Enterprise Value
155.49M
Revenue
4.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.00
Market Cap Chart
Since June 29, 2009, Scancell Holdings's market cap has increased from 3.13M to 147.88M, an increase of 4,618.63%. That is a compound annual growth rate of 25.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 147.88M | 43.94% |
| Dec 31, 2025 | 102.74M | -6.96% |
| Dec 31, 2024 | 110.43M | 28.31% |
| Dec 29, 2023 | 86.06M | -57.34% |
| Dec 30, 2022 | 201.77M | 23.75% |
| Dec 31, 2021 | 163.04M | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oxford Biomedica | 748.50M |
| Avacta Group | 339.59M |
| PureTech Health | 302.33M |
| Faron Pharmaceuticals Oy | 94.23M |
| Bioventix | 83.60M |
| 4basebio | 81.58M |
| Ondine Biomedical | 77.41M |
| Hemogenyx Pharmaceuticals | 52.36M |